Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore

International Journal of Cancer

Volumn 132, Issue 4, 2012, Pages 891-896

  Wu, Anna H ^a   Stanczyk, Frank Z ^a   Wang, Renwei ^b   Koh, Woon Puay ^c   Yuan, Jian Min ^b   Yu, Mimi C ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NONE

Author keywords

breast cancer; prospective; Singaporean Chinese; sleep duration; spot urinary melatonin

Indexed keywords

6 HYDROXYMELATONIN O SULFATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SINGAPORE; SLEEP TIME; URINALYSIS; URINE LEVEL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; RISK FACTORS; SINGAPORE; SLEEP; SLEEP DEPRIVATION;

EID: 84871360455     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27653     Document Type: Article

References (20)

1. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007; 8: 1065-6.
2. Travis RC, Allen DS, Fentiman IS, et al. Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 2004; 96: 475-82. (Pubitemid 38443651)
3. Schernhammer ES, Berrino F, Krogh V, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008; 100: 898-905. (Pubitemid 351881952)
4. Schernhammer ES, Berrino F, Krogh V, et al. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2010; 19: 729-37.
5. Schernhammer ES, Hankinson SE,. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005; 97: 1084-7. (Pubitemid 41417926)
6. Schernhammer ES, Hankinson SE,. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev 2009; 18: 74-9.
7. Pinheiro SP, Schernhammer ES, Tworoger SS, et al. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 2006; 66: 5521-5. (Pubitemid 43844981)
8. Verkasalo PK, Lillberg K, Stevens RG, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res 2005; 65: 9595-600. (Pubitemid 41508031)
9. Kakizaki M, Kuriyama S, Sone T, et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 2008; 99: 1502-5.
10. Wu AH, Wang R, Koh WP, et al. Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 2008; 29: 1244-8. (Pubitemid 351958705)
11. Cook MR, Graham C, Kavet R, et al. Morning urinary assessment of nocturnal melatonin secretion in older women. J Pineal Res 2000; 28: 41-7. (Pubitemid 30066051)
12. Lang U, Kornemark M, Aubert ML, et al. Radioimmunological determination of urinary melatonin in humans: correlation with plasma levels and typical 24-hour rhythmicity. J Clin Endocrinol Metab 1981; 53: 645-50. (Pubitemid 12005815)
13. Hankin JH, Stram DO, Arakawa K, et al. Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer 2001; 39: 187-95. (Pubitemid 33694034)
14. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Lyon: IARC, 2002.
15. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-36. (Pubitemid 34983222)
16. Seow A, Shi CY, Chung FL, et al. Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomarkers Prev 1998; 7: 775-81. (Pubitemid 28420615)
17. Erren TC, Reiter RJ,. Light hygiene: time to make preventive use of insights-old and new-into the nexus of the drug light, melatonin, clocks, chronodisruption and public health. Med Hypotheses 2009; 73: 537-41.
18. Reiter RJ, Tan DX, Erren TC, et al. Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. Integr Cancer Ther 2009; 8: 354-60.
19. Stevens RG, Blask DE, Brainard GC, et al. Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect 2007; 115: 1357-62. (Pubitemid 47471261)
20. Hsing AW, Meyer TE, Niwa S, et al. Measuring serum melatonin in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2010; 19: 932-7.